Correlation Between X4 Pharmaceuticals and Ginkgo Bioworks

Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Ginkgo Bioworks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Ginkgo Bioworks into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between X4 Pharmaceuticals and Ginkgo Bioworks Holdings, you can compare the effects of market volatilities on X4 Pharmaceuticals and Ginkgo Bioworks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Ginkgo Bioworks. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Ginkgo Bioworks.

Diversification Opportunities for X4 Pharmaceuticals and Ginkgo Bioworks

0.16

Correlation Coefficient

X4 Pharmaceuticals  Ginkgo Bioworks

Average diversification

The 3 months correlation between XFOR and Ginkgo is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Ginkgo Bioworks Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ginkgo Bioworks Holdings and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Ginkgo Bioworks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ginkgo Bioworks Holdings has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Ginkgo Bioworks go up and down completely randomly.

Pair Corralation between X4 Pharmaceuticals and Ginkgo Bioworks

Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 1.21 times more return on investment than Ginkgo Bioworks. However, X4 Pharmaceuticals is 1.21 times more volatile than Ginkgo Bioworks Holdings. It trades about 0.02 of its potential returns per unit of risk. Ginkgo Bioworks Holdings is currently generating about -0.07 per unit of risk. If you would invest  99.00  in X4 Pharmaceuticals on September 26, 2024 and sell it today you would lose (41.00) from holding X4 Pharmaceuticals or give up 41.41% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

X4 Pharmaceuticals  vs.  Ginkgo Bioworks Holdings

X4 Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in X4 Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, X4 Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Ginkgo Bioworks Holdings

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Ginkgo Bioworks Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Ginkgo Bioworks sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with X4 Pharmaceuticals and Ginkgo Bioworks

The main advantage of trading using opposite X4 Pharmaceuticals and Ginkgo Bioworks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Ginkgo Bioworks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will offset losses from the drop in Ginkgo Bioworks' long position.

The idea behind X4 Pharmaceuticals and Ginkgo Bioworks Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.